- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04935164
Comparative Study of Gender Identity Disorder Versus Control (TRANSIDENT)
June 3, 2025 updated by: Centre Hospitalier Henri Laborit
Comparative Study of Gender Dysphoria Phenomenology and Neurophysiology: Clinical and Experimental Exploration of Gender Identity Disorder
Gender dysphoria is manifested by an internal tension between biological sex and gender, that is, by a non-congruence, in the subjects who suffer from it, between their sex of birth and their social gender identity.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Detailed Description
Gender dysphoria is manifested by an internal tension between biological sex and gender, that is, by a non-congruence, in the subjects who suffer from it, between their sex of birth and their social gender identity.
Gender dysphoria is accompanied by the often overwhelming need for a hormonal or even hormone-surgical transition.
Gender dysphoria is very often characterized by fluctuating mood sadness, irritability, obsessionality.
An improvement in the quality of life after medical treatment (hormone therapy) and gender reassignment surgery has been described in the literature.
Morphological similarities have been found between the brains of women and the brains of so-called transgender women, as well as between the brains of transgender men and men.
These morphological data are only very fragmentary and have not been supported by neuro-functional data.
Self-awareness, which refers to the awareness that an individual has of his body, his image and his own identity, is partly underpinned, at the brain level, by the activation of the Default Mode Network (DMN) at rest, in non-pathological conditions.
The conflict between the internal perception of the own body and its objective representation could result in a change in brain connectivity within the DMN, due in particular to changes in the activation of the temporo parietal junction.
Study Type
Observational
Enrollment (Estimated)
120
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Bérangère Thirioux, PhD
- Phone Number: 0033 5 49 44 58 56
- Email: berangere.thirioux@ch-poitiers.fr
Study Locations
-
-
-
Poitiers, France, 86021
- Recruiting
- Centre Hospitalier Henri Laborit
-
Contact:
- Bérangère Thirioux, PhD
- Email: berangere.thirioux@ch-poitiers.fr
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 60 years (Adult)
Accepts Healthy Volunteers
Yes
Sampling Method
Non-Probability Sample
Study Population
Contact sponsor for more details
Description
Inclusion Criteria:
- Patients with gender dysphoria
- Without psychotropic
- Without hormono-therapy
- Without sexual surgery assignation
Exclusion Criteria:
- Any depression
- Any addiction
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Male patients with gender dysphoria
|
At different time points, several psychiatric evaluations will be performed on patients and volunteers for study purposes
Other Names:
|
|
Female patients with gender dysphoria
|
At different time points, several psychiatric evaluations will be performed on patients and volunteers for study purposes
Other Names:
|
|
Male volunteers without gender dysphoria
|
At different time points, several psychiatric evaluations will be performed on patients and volunteers for study purposes
Other Names:
|
|
Female volunteers without gender dysphoria
|
At different time points, several psychiatric evaluations will be performed on patients and volunteers for study purposes
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Contribution of temporal parameters of microstates C, D, E and F
Time Frame: Week 1 to Week 24
|
The proportion of the total time spent in microstates of class C,D,E and F
|
Week 1 to Week 24
|
|
Duration of temporal parameters of microstates C, D, E and F
Time Frame: Week 1 to Week 24
|
Week 1 to Week 24
|
|
|
Mean-Global Field Power temporal parameters of microstates C, D, E and F
Time Frame: Week 1 to Week 24
|
Week 1 to Week 24
|
|
|
Occurrence of temporal parameters of microstates C, D, E and F
Time Frame: Week 1 to Week 24
|
Week 1 to Week 24
|
|
|
Cortical voxel activity from source reconstruction analysis, using electroencephalogram during Double Mirror Test (D.M.T).
Time Frame: Week 1 to Week 24
|
Week 1 to Week 24
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 26, 2021
Primary Completion (Estimated)
March 1, 2029
Study Completion (Estimated)
December 1, 2029
Study Registration Dates
First Submitted
February 26, 2021
First Submitted That Met QC Criteria
June 21, 2021
First Posted (Actual)
June 22, 2021
Study Record Updates
Last Update Posted (Estimated)
June 5, 2025
Last Update Submitted That Met QC Criteria
June 3, 2025
Last Verified
June 1, 2025
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2020-A03407-32
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Gender Dysphoria, Adult
-
University Hospitals Cleveland Medical CenterKerecis Ltd.RecruitingGender Dysphoria, AdultUnited States
-
Region SkaneRecruiting
-
University of ChicagoNot yet recruitingGender Dysphoria, Adult | VaginoplastyUnited States
-
Rigshospitalet, DenmarkRecruitingGender Identity | Gender Incongruence | Gender Dysphoria, AdultDenmark
-
Region SkaneLund UniversityNot yet recruitingPsychiatric Comorbidities | Gender Dysphoria, AdultSweden
-
Dartmouth-Hitchcock Medical CenterNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National... and other collaboratorsEnrolling by invitationGender Dysphoria | Transgender Persons | Transsexualism | Transgenderism | Gender Incongruence | Phalloplasty | Gender Dysphoria, AdultUnited States
-
Tel-Aviv Sourasky Medical CenterCompletedTransgender Women | Hemostasis | Blood Coagulation | Transgender Persons, M01.777.500 | Coagulation Factors | Gender Dysphoria, AdultIsrael
-
Amsterdam UMC, location VUmcRecruitingGender Dysphoria, AdolescentNetherlands
-
University Hospital, ToulouseCompletedGender Dysphoria, AdolescentFrance
-
Weill Medical College of Cornell UniversityIcahn School of Medicine at Mount Sinai; The Cleveland Clinic; Boston Medical...UnknownGender Identity Disorder of Adult | Voiding Disorders | Sexual DysfunctionUnited States
Clinical Trials on Psychiatric evaluations
-
University Hospital, MontpellierBeziers HospitalRecruiting
-
Centre Hospitalier Universitaire de BesanconUnknown
-
Fondation Korian pour le Bien VieillirGerontopôle des Pays de la LoireCompleted
-
Gaziler Physical Medicine and Rehabilitation Education...RecruitingAmputation, TraumaticTurkey
-
Fondazione IRCCS Ca' Granda, Ospedale Maggiore...Not yet recruiting
-
Jeanne et Leon DeveloppementGerontopôle des Pays de la LoireRecruitingResidents's Frailty in Temporary Accommodation | Residents's Quality of Life in Temporary AccommodationFrance
-
Pierre Fabre Dermo CosmetiqueCompletedAtopic DermatitisFrance
-
Lokman Hekim UniversityEnrolling by invitationDuchenne Muscular Dystrophy | Executive Dysfunction | Occupational ProblemsTurkey (Türkiye)
-
Neuromed IRCCSEnrolling by invitationStroke | Epilepsy | Multiple Sclerosis | Parkinson Disease | DementiaItaly
-
Sheba Medical CenterCompletedLate Effects of Cerebrovascular Accident